Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.06% Nasdaq Down0.01%

Halozyme Therapeutics, Inc. (HALO)

-NasdaqGS

7.42 Down 0.03(0.40%) 4:00PM EDT - Nasdaq Real Time Price

Add to Portfolio
Key StatisticsGet Key Statistics for:
Data provided by Capital IQ, except where noted.
Valuation Measures 
Market Cap (intraday)5:834.13M
Enterprise Value (May 24, 2013)3:838.55M
Trailing P/E (ttm, intraday):N/A
Forward P/E (fye Dec 31, 2014)1:N/A
PEG Ratio (5 yr expected)1:N/A
Price/Sales (ttm):17.93
Price/Book (mrq):26.42
Enterprise Value/Revenue (ttm)3:17.95
Enterprise Value/EBITDA (ttm)6:-15.02
Financial Highlights 
Fiscal Year
Fiscal Year Ends:Dec 30
Most Recent Quarter (mrq):Mar 31, 2013
Profitability
Profit Margin (ttm):-123.55%
Operating Margin (ttm):-121.97%
Management Effectiveness
Return on Assets (ttm):-28.31%
Return on Equity (ttm):-102.40%
Income Statement
Revenue (ttm):46.72M
Revenue Per Share (ttm):0.42
Qtrly Revenue Growth (yoy):59.00%
Gross Profit (ttm):41.23M
EBITDA (ttm)6:-55.84M
Net Income Avl to Common (ttm):-57.72M
Diluted EPS (ttm):-0.51
Qtrly Earnings Growth (yoy):N/A
Balance Sheet
Total Cash (mrq):87.43M
Total Cash Per Share (mrq):0.78
Total Debt (mrq):31.14M
Total Debt/Equity (mrq):98.28
Current Ratio (mrq):5.63
Book Value Per Share (mrq):0.28
Cash Flow Statement
Operating Cash Flow (ttm):-55.72M
Levered Free Cash Flow (ttm):-34.38M
View Financials
Income Statement - Balance Sheet - Cash Flow
Trading Information 
Stock Price History
Beta:1.45
52-Week Change3:-10.35%
S&P500 52-Week Change3:25.25%
52-Week High (Jul 27, 2012)3:9.92
52-Week Low (Aug 2, 2012)3:3.86
50-Day Moving Average3:6.25
200-Day Moving Average3:6.19
Share Statistics
Avg Vol (3 month)3:1,377,040
Avg Vol (10 day)3:2,449,650
Shares Outstanding5:112.42M
Float:64.32M
% Held by Insiders1:3.87%
% Held by Institutions1:67.40%
Shares Short (as of Apr 30, 2013)3:9.66M
Short Ratio (as of Apr 30, 2013)3:9.80
Short % of Float (as of Apr 30, 2013)3:10.90%
Shares Short (prior month)3:8.68M
Dividends & Splits
Forward Annual Dividend Rate4:N/A
Forward Annual Dividend Yield4:N/A
Trailing Annual Dividend Yield3:N/A
Trailing Annual Dividend Yield3:N/A
5 Year Average Dividend Yield4:N/A
Payout Ratio4:N/A
Dividend Date3:N/A
Ex-Dividend Date4:N/A
Last Split Factor (new per old)2:N/A
Last Split Date3:N/A

See Key Statistics Help for definitions of terms used.
Abbreviation Guide: K = Thousands; M = Millions; B = Billions
mrq = Most Recent Quarter (as of Mar 31, 2013)
ttm = Trailing Twelve Months (as of Mar 31, 2013)
yoy = Year Over Year (as of Mar 31, 2013)
lfy = Last Fiscal Year (as of Dec 31, 2012)
fye = Fiscal Year Ending
1 Data provided by Thomson Reuters
2 Data provided by EDGAR Online
3 Data derived from multiple sources or calculated by Yahoo! Finance
4 Data provided by Morningstar, Inc.
5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
6 EBITDA is calculated by Capital IQ using methodology that may differ from that used by a company in its reporting

Currency in USD.